HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 1 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,819,816 | -18.2% | 266,400 | -27.3% | 0.66% | -4.1% |
Q2 2023 | $37,684,240 | +38.1% | 366,400 | +46.6% | 0.68% | +27.4% |
Q1 2023 | $27,285,000 | +40.2% | 250,000 | +46.2% | 0.54% | +44.1% |
Q4 2022 | $19,459,800 | -88.4% | 171,000 | -91.9% | 0.37% | -87.8% |
Q2 2022 | $168,178,000 | -27.2% | 2,108,555 | -4.0% | 3.05% | -18.7% |
Q1 2022 | $231,100,000 | -14.2% | 2,196,555 | -12.1% | 3.75% | +8.2% |
Q4 2021 | $269,406,000 | -5.8% | 2,500,055 | -4.2% | 3.46% | +10.2% |
Q3 2021 | $285,938,000 | +4.5% | 2,610,355 | -10.7% | 3.14% | +13.5% |
Q2 2021 | $273,631,000 | -5.5% | 2,922,155 | -7.1% | 2.77% | +2.3% |
Q1 2021 | $289,406,000 | +31.5% | 3,144,355 | +4.5% | 2.71% | +40.5% |
Q4 2020 | $220,090,000 | -5.8% | 3,008,755 | 0.0% | 1.93% | -34.4% |
Q3 2020 | $233,720,000 | +46.6% | 3,008,755 | +4.9% | 2.94% | +30.9% |
Q2 2020 | $159,398,000 | +129.8% | 2,867,910 | +22.5% | 2.24% | +92.5% |
Q1 2020 | $69,361,000 | +21.1% | 2,341,700 | +48.0% | 1.17% | +42.5% |
Q4 2019 | $57,279,000 | – | 1,582,300 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |